TNM classification for lung cancer

Area of Science:

• Oncology
• Cancer Staging
• Thoracic Surgery

Background:

• The Tumor-Node-Metastasis (TNM) staging system is crucial for lung cancer diagnosis and treatment.
• Six revisions of the TNM system for lung cancer have occurred since 1968.
• The 1997 revision aimed to correct deficiencies but still faces challenges.

Purpose of the Study:

• To discuss existing controversies and proposed revisions for the TNM staging system in lung cancer.
• To critically evaluate specific aspects of the current TNM classification.
• To highlight areas needing further refinement for improved accuracy.

Main Methods:

• Review and discussion of current TNM staging criteria for lung cancer.
• Analysis of controversies regarding tumor size cut-offs (T1/T2 at 3 cm).
• Examination of subdivisions (T1a/b, T2a/b), T4 definitions, and lymph node station boundaries (N1/N2).

Main Results:

• Questions raised about the 3 cm cut-off for T1/T2 and the validity of T1a/b and T2a/b subdivisions.
• Concerns regarding the down-staging of T3N0M0 to stage IIB due to T3 heterogeneity.
• Discrepancies in lymph node maps and classification of separate tumor nodules (STN).

Conclusions:

• The current TNM staging system for lung cancer, despite improvements, contains several controversial elements.
• These controversies include tumor size criteria, lymph node mapping, and stage grouping validity.
• Further revisions are proposed to enhance the accuracy and clinical utility of lung cancer staging.